Evidence map›Paper›PMID 26561648›Full record

ArticleAmerican journal of physiology. Regulatory, integrative and comparative physiology2016

Neuronostatin acts via GPR107 to increase cAMP-independent PKA phosphorylation and proglucagon mRNA accumulation in pancreatic α-cells.

Mollisa M Elrick, Willis K Samson, John A Corbett, Alison S Salvatori, Lauren M Stein, Grant R Kolar, Aaron Naatz, Gina L C Yosten

Open access · bronzeAbstract read
In one paragraph

Article in American journal of physiology. Regulatory, integrative and comparative physiology, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed
3.2field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed, 41 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Review
  6. Review
  7. Review
  8. Article
  9. Review
  10. Review
  11. Review
  12. Article
  13. Article
  14. Article
  15. Looking Back on Seven Years ofAmerican journal of physiology. Regulatory, integrative and comparative physiology · 2020
    Article
  16. Article
  17. Article
  18. Review
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Mollisa M ElrickDepartment of Pharmacological and Physiological Science, Saint Louis University School of Medicine, St. Louis, Missouri;
Willis K SamsonDepartment of Pharmacological and Physiological Science, Saint Louis University School of Medicine, St. Louis, Missouri;
John A CorbettDepartment of Biochemistry, Medical College of Wisconsin, Milwaukee, Wisconsin.
Alison S SalvatoriDepartment of Pharmacological and Physiological Science, Saint Louis University School of Medicine, St. Louis, Missouri;
Lauren M SteinDepartment of Pharmacological and Physiological Science, Saint Louis University School of Medicine, St. Louis, Missouri;
Grant R KolarDepartment of Pathology, Saint Louis University School of Medicine, St. Louis, Missouri; and.
Aaron NaatzDepartment of Biochemistry, Medical College of Wisconsin, Milwaukee, Wisconsin.
Gina L C YostenDepartment of Pharmacological and Physiological Science, Saint Louis University School of Medicine, St. Louis, Missouri; gyosten@slu.edu.
Saint Louis University · USMedical College of Wisconsin · US

Funding

BIOCHEMICAL MECHANISM OF BETA-CELL DESTRUCTIONR01DK052194 · NIDDK · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI CORBETT, JOHN A · 1998 to 2025
$8.8M
MECHANISMS OF VIRAL INDUCED BETA CELL DAMAGER01AI044458 · NIAID · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI CORBETT, JOHN A · 1998 to 2024
$7.5M
NHLBI NIH HHS HL-06623NIAID NIH HHS R01 AI044458NIDDK NIH HHS DK-052194NIDDK NIH HHS R01 DK052194
6 · The paper itself

Abstract

Neuronostatin (NST) is a recently described peptide that is produced from the somatostatin preprohormone in pancreatic δ-cells. NST has been shown to increase glucagon secretion from primary rat pancreatic islets in low-glucose conditions. Here, we demonstrate that NST increases proglucagon message in α-cells and identify a potential mechanism for NST's cellular activities, including the phosphorylation of PKA following activation of the G protein-coupled receptor, GPR107. GPR107 is abundantly expressed in the pancreas, particularly, in rodent and human α-cells. Compromise of GPR107 in pancreatic α-cells results in failure of NST to increase PKA phosphorylation and proglucagon mRNA levels. We also demonstrate colocalization of GPR107 and NST on both mouse and human pancreatic α-cells. Taken together with our group's observation that NST infusion in conscious rats impairs glucose clearance in response to a glucose challenge and that plasma levels of the peptide are elevated in the fasted compared with the fed or fasted-refed state, these studies support the hypothesis that endogenous NST regulates islet cell function by interacting with GPR107 and initiating signaling in glucagon-producing α-cells.

Indexed as

AnimalsCell LineCyclic AMPCyclic AMP-Dependent Protein KinasesGlucagon-Secreting CellsHumansMaleMicePeptide FragmentsPeptide HormonesPhosphorylationProglucagonRats, Sprague-DawleyReceptors, G-Protein-CoupledRNA InterferenceRNA, MessengerCyclic AMPCyclic AMP-Dependent Protein KinasesGPR107 protein, mouseGPR107 protein, ratneuronostatin, humanneuronostatin, mouseneuronostatin protein, ratPeptide FragmentsPeptide HormonesProglucagonReceptors, G-Protein-CoupledRNA, MessengerSomatostatincAMP-independent PKA activationglucagonglucose homeostasisGPR107islet functionneuronostatin

Identifiers

PMID26561648
PMCPMC4796643
OpenAlexW2319307509

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.